SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- HIV -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (90)2/21/2009 9:49:56 PM
From: Elroy Jetson  Respond to of 155
 
There will always be a certain market for combination tablets, but I think this niche is far smaller than you believe.

If the combination tablet Atripla were not as heavily discounted as it is, when compared with it's individual components, the sales would certainly be far smaller than it is now.
.



To: DewDiligence_on_SI who wrote (90)2/22/2009 12:51:40 PM
From: tuck  Respond to of 155
 
Hey, hey, now. This has been a very informative dialogue for me and I'm sure others as well. Let's keep it civil so it keeps going. Maybe you guys could post some references that defend those positions of yours that are in contention here?

Thanks to both of you!

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News